vs

Side-by-side financial comparison of DAILY JOURNAL CORP (DJCO) and STANDARD BIOTOOLS INC. (LAB). Click either name above to swap in a different company.

STANDARD BIOTOOLS INC. is the larger business by last-quarter revenue ($19.6M vs $19.5M, roughly 1.0× DAILY JOURNAL CORP). DAILY JOURNAL CORP runs the higher net margin — -40.8% vs -177.4%, a 136.6% gap on every dollar of revenue. On growth, DAILY JOURNAL CORP posted the faster year-over-year revenue change (10.4% vs -11.5%). DAILY JOURNAL CORP produced more free cash flow last quarter ($-1.9M vs $-23.1M). Over the past eight quarters, DAILY JOURNAL CORP's revenue compounded faster (8.6% CAGR vs -12.2%).

Daily Journal Corporation is an American publishing company and technology company headquartered in Los Angeles, California. The company has offices in the California cities of Corona, Oakland, Riverside, Sacramento, San Diego, San Francisco, San Jose, and Santa Ana, as well as in Denver, Colorado; Logan, Utah; Phoenix, Arizona; and Melbourne, Australia. Since being led by Charles T. Munger, its newspapers have focused greatly on reporting about the U.S. legal system.

Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits (IFCs), and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.

DJCO vs LAB — Head-to-Head

Bigger by revenue
LAB
LAB
1.0× larger
LAB
$19.6M
$19.5M
DJCO
Growing faster (revenue YoY)
DJCO
DJCO
+21.8% gap
DJCO
10.4%
-11.5%
LAB
Higher net margin
DJCO
DJCO
136.6% more per $
DJCO
-40.8%
-177.4%
LAB
More free cash flow
DJCO
DJCO
$21.1M more FCF
DJCO
$-1.9M
$-23.1M
LAB
Faster 2-yr revenue CAGR
DJCO
DJCO
Annualised
DJCO
8.6%
-12.2%
LAB

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
DJCO
DJCO
LAB
LAB
Revenue
$19.5M
$19.6M
Net Profit
$-8.0M
$-34.7M
Gross Margin
48.5%
Operating Margin
2.4%
-168.5%
Net Margin
-40.8%
-177.4%
Revenue YoY
10.4%
-11.5%
Net Profit YoY
-173.2%
-28.8%
EPS (diluted)
$-5.79
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DJCO
DJCO
LAB
LAB
Q4 25
$19.5M
Q3 25
$28.4M
$19.6M
Q2 25
$23.4M
$21.8M
Q1 25
$18.2M
$40.8M
Q4 24
$17.7M
Q3 24
$19.9M
$22.1M
Q2 24
$17.5M
$22.5M
Q1 24
$16.6M
$45.5M
Net Profit
DJCO
DJCO
LAB
LAB
Q4 25
$-8.0M
Q3 25
$42.2M
$-34.7M
Q2 25
$14.4M
$-33.5M
Q1 25
$44.7M
$-26.0M
Q4 24
$10.9M
Q3 24
$26.7M
$-26.9M
Q2 24
$23.4M
$-45.7M
Q1 24
$15.4M
$-32.2M
Gross Margin
DJCO
DJCO
LAB
LAB
Q4 25
Q3 25
48.5%
Q2 25
48.8%
Q1 25
48.4%
Q4 24
Q3 24
54.9%
Q2 24
46.1%
Q1 24
53.1%
Operating Margin
DJCO
DJCO
LAB
LAB
Q4 25
2.4%
Q3 25
16.2%
-168.5%
Q2 25
13.8%
-118.1%
Q1 25
5.3%
-80.8%
Q4 24
4.2%
Q3 24
8.7%
-120.9%
Q2 24
6.2%
-134.5%
Q1 24
3.8%
-132.2%
Net Margin
DJCO
DJCO
LAB
LAB
Q4 25
-40.8%
Q3 25
148.3%
-177.4%
Q2 25
61.6%
-153.7%
Q1 25
245.8%
-63.8%
Q4 24
61.5%
Q3 24
134.5%
-122.0%
Q2 24
133.5%
-203.3%
Q1 24
93.0%
-70.6%
EPS (diluted)
DJCO
DJCO
LAB
LAB
Q4 25
$-5.79
Q3 25
$-0.09
Q2 25
$-0.09
Q1 25
$-0.07
Q4 24
$7.91
Q3 24
$-0.07
Q2 24
$-0.12
Q1 24
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DJCO
DJCO
LAB
LAB
Cash + ST InvestmentsLiquidity on hand
$497.9M
$129.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$383.1M
$399.7M
Total Assets
$529.5M
$539.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DJCO
DJCO
LAB
LAB
Q4 25
$497.9M
Q3 25
$513.6M
$129.4M
Q2 25
$461.7M
$158.6M
Q1 25
$443.3M
$150.9M
Q4 24
$387.2M
Q3 24
$371.7M
$210.6M
Q2 24
$335.0M
$269.8M
Q1 24
$307.6M
$287.1M
Total Debt
DJCO
DJCO
LAB
LAB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$55.2M
Q2 24
$55.1M
Q1 24
$55.0M
Stockholders' Equity
DJCO
DJCO
LAB
LAB
Q4 25
$383.1M
Q3 25
$391.1M
$399.7M
Q2 25
$348.9M
$424.5M
Q1 25
$334.4M
$454.6M
Q4 24
$289.7M
Q3 24
$278.8M
$489.3M
Q2 24
$251.9M
$510.3M
Q1 24
$228.5M
$577.3M
Total Assets
DJCO
DJCO
LAB
LAB
Q4 25
$529.5M
Q3 25
$548.1M
$539.6M
Q2 25
$494.7M
$557.0M
Q1 25
$468.1M
$579.6M
Q4 24
$412.6M
Q3 24
$403.8M
$681.5M
Q2 24
$369.9M
$708.7M
Q1 24
$335.7M
$777.7M
Debt / Equity
DJCO
DJCO
LAB
LAB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.11×
Q2 24
0.11×
Q1 24
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DJCO
DJCO
LAB
LAB
Operating Cash FlowLast quarter
$-1.9M
$-22.2M
Free Cash FlowOCF − Capex
$-1.9M
$-23.1M
FCF MarginFCF / Revenue
-10.0%
-118.1%
Capex IntensityCapex / Revenue
0.0%
4.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-111.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DJCO
DJCO
LAB
LAB
Q4 25
$-1.9M
Q3 25
$4.5M
$-22.2M
Q2 25
$7.2M
$-20.7M
Q1 25
$-569.0K
$-30.3M
Q4 24
$2.2M
Q3 24
$3.1M
$-27.9M
Q2 24
$1.6M
$-39.0M
Q1 24
$-3.7M
$-62.5M
Free Cash Flow
DJCO
DJCO
LAB
LAB
Q4 25
$-1.9M
Q3 25
$-23.1M
Q2 25
$-22.6M
Q1 25
$-35.3M
Q4 24
Q3 24
$3.1M
$-30.1M
Q2 24
$1.6M
$-41.0M
Q1 24
$-3.7M
$-63.3M
FCF Margin
DJCO
DJCO
LAB
LAB
Q4 25
-10.0%
Q3 25
-118.1%
Q2 25
-103.6%
Q1 25
-86.6%
Q4 24
Q3 24
15.5%
-136.4%
Q2 24
9.1%
-182.2%
Q1 24
-22.1%
-138.9%
Capex Intensity
DJCO
DJCO
LAB
LAB
Q4 25
0.0%
Q3 25
4.5%
Q2 25
0.0%
8.7%
Q1 25
12.4%
Q4 24
0.0%
Q3 24
0.2%
10.2%
Q2 24
0.1%
8.6%
Q1 24
0.1%
1.7%
Cash Conversion
DJCO
DJCO
LAB
LAB
Q4 25
Q3 25
0.11×
Q2 25
0.50×
Q1 25
-0.01×
Q4 24
0.20×
Q3 24
0.12×
Q2 24
0.07×
Q1 24
-0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DJCO
DJCO

License And Maintenance$8.5M44%
Service Other$4.5M23%
Advertising Service Fees And Other$3.3M17%
Consulting Fees$2.2M11%
Subscription And Circulation$1.1M6%

LAB
LAB

Consumables$8.7M45%
Services And Other Revenue$5.8M29%
Instruments$5.1M26%

Related Comparisons